Infectious disease lab expands to Texas
Subscriber Benefit
As a subscriber you can listen to articles at work, in the car, or while you work out. Subscribe Now
Indianapolis-based Patients Choice Laboratories says it has acquired Infinity Laboratories LLC, an infectious disease lab based in Texas. PCL says the purchase will allow it to expand its footprint into the southern U.S.
Patients Choice specializes in infectious disease, pharmacogenetics, blood work and toxicology.
“We have a proud history of assisting providers in accelerating their decision-making process for treatment, providing the fastest turnaround times in the lab industry, and working with some of the leading health systems and providers in the nation,” said PCL President Brad Moss.
PCL says it uses molecular diagnostics to provide custom treatment recommendations based on antibiotic-resistant genes found in infections.
Terms of the deal were not disclosed.